Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors

Presenters/Authors

• Richard J. Hammond, Armstrong Atlantic State UniversityFollow
• Benjamin W. Poston, Armstrong Atlantic State UniversityFollow
• Brent D. Feske, Georgia Southern UniversityFollow

Document Type

Presentation

Presentation Date

1-1-2007

Copyright

This work is archived and distributed under the repository's Standard Copyright and Reuse License (opens in new tab). End users may copy, store, and distribute this work without restriction. For all other uses, permission must be obtained from the copyright owners or their authorized agents.

Abstract or Description

This presentation was given at the ACS National Meeting.

Sponsorship/Conference/Institution

ACS National Meeting

Location

Boston, MA

Recommended Citation

Hammond, Richard J., Benjamin W. Poston, Brent D. Feske. 2007. "Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors." Chemistry: Faculty Presentations (1990-2022). Presentation 238.
https://digitalcommons.georgiasouthern.edu/chem-facpres/238